Adriano Lazzarin

发表

Selected Pool of Peptides from ESAT-6 and CFP-10 Proteins for Detection of Mycobacterium tuberculosis Infection

Paolo Scarpellini, Silvana Tasca, Laura Galli, 2004, Journal of Clinical Microbiology.

Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting

Laura Galli, Adriano Lazzarin, A. Lazzarin, 2013, Therapeutics and clinical risk management.

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.

Adriano Lazzarin, Patrick Champagne, G. Pantaleo, 2002, The Journal of clinical investigation.

Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials

Adriano Lazzarin, J. Gatell, A. Lazzarin, 2004, Journal of the International Association of Physicians in AIDS Care.

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)

Laura Galli, Adriano Lazzarin, Massimo Clementi, 2006, AIDS.

Survival of Zidovudine-Treated Patients With AIDS Compared With That of Contemporary Untreated Patients

Carlo Tomino, Donato Greco, Marco Floridia, 1992 .

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Adriano Lazzarin, Edwin DeJesus, Peter Sklar, 2009, The Lancet.

Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parameters

Mario Clerici, Adriano Lazzarin, Massimo Alfano, 2002, Perfusion.

Identification and Structural Characterization of Novel Genetic Elements in the HIV-1 V3 Loop Regulating Coreceptor Usage

Stefano Alcaro, Giorgio Palù, Anna Artese, 2011, Antiviral therapy.

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.

Christine Katlama, Joep Lange, Adriano Lazzarin, 2003, The New England journal of medicine.

Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.

Adriano Lazzarin, Massimo Clementi, A. Lazzarin, 2011, The Journal of infectious diseases.

The Efficiency of Male‐to Female and Female‐to‐Male Sexual Transmission of the Human Immunodeficiency Virus: A Study of 730 Stable Couples

Adriano Lazzarin, Alfredo Nicolosi, Massimo Musicco, 1994, Epidemiology.

Offer of rapid testing and alternative biological samples as practical tools to implement HIV screening programs.

Adriano Lazzarin, A. Lazzarin, G. di Perri, 2009, The new microbiologica.

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Bernard Hirschel, Adriano Lazzarin, B. Hirschel, 2008, The New England journal of medicine.

A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.

Anne M Johnson, Jens D. Lundgren, Anders Blaxhult, 1999, Journal of acquired immune deficiency syndromes.